Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: An age-cohort effect for HTLV-II RFLP type a0

Virology

Volumn 242, Issue 2, 1998, Pages 425-434

  Murphy, Edward L ^a,b   Mahieux, Renaud ^b   De Thé, Guy ^b   Tekaia, Fredj ^c   Ameti, Dannie ^d   Horton, Jacqueline ^d   Gessain, Antoine ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Institut Pasteur   (France)

^c INSTITUT PASTEUR   (France)

^d WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 2; RNA VIRUSES;

EID: 0032520533     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.9009     Document Type: Article

References (29)

1. Biggar R. J., Buskell-Bales Z., Yakshe P. N., Caussy D., Gridley G., Seeff L. Antibody to human retroviruses among drug users in three East Coast American cities, 1972-1976. J. Infect. Dis. 163:1991;57-63.
2. Briggs N. C., Battjes R. J., Cantor K. P. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type I coinfection, among US intravenous drug users. J. Infect. Dis. 72:1995;51-58.
3. Cereseto A., Mulloy J. C., Franchini G. Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II. J. Acq. Immun. Defic. Syndr. Hum Retrovir. 13:1996;S69-S75.
4. Chen I. S. Y., McLaughlin J. Gasson J. C., Clark S. C. and Golde D. W. Molecular characterization of genome of a novel human T-cell leukemia virus. Nature. 305:1983;502-505.
5. Eiraku N., Monken C., Kubo T. Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS. Res. Hum. Retrovir. 11:1995;625-636.
6. Feigal E., Murphy E. L., Vranizan K. HTLV-I/II in intravenous drug users in San Francisco: Risk factors associated with seropositivity. J. Infect. Dis. 164:1991;36-42.
7. Gessain A., Mauclere P., Froment A. Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: An ancient origin for HTLV-II in Africa. Proc. Nat. Acad. Sci. USA. 92:1995;4041-4045.
8. Goubau P., Desmyter J., Ghesquiere J., Kasereka B. HTLV-II among pygmies. Nature. 359:1992;201.
9. Hall W. W., Ishak R., Zhu S. W. Human T-lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J. Acq. Immun. Defic. Syndr. Hum. Retrovir. 13:1996;S204-S214.
10. Heneine W. The phylogeny and molecular epidemiology of human T-cell lymphotropic virus type II. J. Acq. Immun. Defic. Syndr. Hum. Retrovir. 13:1996;S236-241.
11. Hjelle B., Khabbaz R. F., Conway G. A., North G., Green D., Kaplan J. E. Prevalence of human T-cell lymphotropic virus type II in American Indian populations of the southwestern United States. Am. J. Trop. Med. Hyg. 51:1994;11-15.
12. Igarashi T., Yamashita M., Miura T. Isolation and genomic analysis of human T lymphotropic virus type II from Ghana. AIDS. Res. Hum. Retrovir. 9:1993;1039-1042.
13. Kalyanaraman V. S., Sarngadharan M. G., Robert-Guroff M. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 218:1982;571-573.
14. Kaplan J., Khabbaz R. F., Murphy E. L. Male-to-female transmission of human T-lymphotropic virus types I and II: association with viral load. J. Acq. Immun. Defic. Syndr. Hum. Retrovirol. 12:1996;193-201.
15. Khabbaz R. F., Hartel D., Lairmore M. Human T-lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: An old infection. J. Infect. Dis. 163:1991;252-256.
16. Khabbaz R. F., Onorato I. M., Cannon R. O. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually-transmitted diseases. N. Engl. J. Med. 326:1992;375-380.
17. Lal R. B., Gongora-Biachi R. A., Pardi D., Switzer W. M., Goldman I., Lal A. F. Evidence of mother-to-child transmission of human T lymphotropic virus type II. J. Infect. Dis. 168:1993;586-591.
18. Maloney E. M., Biggar R. J., Neel J. V. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J. Infect. Dis. 166:1992;100-107.
19. Mauclere P., Mahieux R., Garcia-Calleja J. M. A new HTLV type II subtype A isolate in an HIV type 1-infected prostitute from Cameroon, Central Africa. AIDS. Res. Hum. Retrovir. 11:1995;989-993.
20. Murphy E. L., Fridey J., Smith J. W. High prevalence of HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II infected blood donors. Neurology. 48:1997;315-320.
21. Schreiber G. B., Murphy E. L., Horton J. A. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: The Retrovirus Epidemiology Donor Study. J. Acq. Immun. Defic. Syndr Hum Retrovir. 14:1997;263-271.
22. Switzer W. M., Pieniazek D., Swanson P. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J. Virol. 69:1995;621-632.
23. Switzer W. M., Black F. L., Pieniazek D., Biggar R. J., Lal R.B., Heneine W. Endemicity and phylogeny of the human T-cell lymphotropic virus type II subtype A from the Kayapo Indians of Brazil: Evidence for limited regional dissemination. AIDS. Res. Hum. Retrovir. 12:1996;635-640.
24. Thompson J. D., Higgins D. G., Gibson T. J. Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acid Res. 22:1994;4673-4680.
25. Tuppin P., Gessain A., Kazanji M. Evidence for an intrafamilial clustering with mother-to-child and sexual transmission of a new molecular variant of human T-lymphotropic virus type-II subtype B. J. Med. Virol. 48:1996;22-32.
26. Vallejo A., Ferrante P., Soriano V. Nucleotide sequence and restriction fragment length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe. Evidence for the HTLV-IIa and HTLV-IIb subtypes. J. Acq. Immun. Defic. Syndr. Hum. Retrovirol. 13:1996;384-391.
27. Vandamme A-M., Liu H-F., Van Brussel M., De Meurichy W., Desmyter J., Goubau P. The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/ simian T-lymphotropic group of viruses. J. Gen. Virol. 77:1996;1089-1099.
28. Vitek C. R., Gracia F. I., Giusti R. A. Evidence for sexual and mother to child transmission of human T-lymphotropic virus type II among Guaymi Indians, Panama. J. Infect. Dis. 171:1995;1022-1026.
29. Vlahov D., Khabbaz R. F., Cohn S., Galai N., Taylor E., Kaplan J. E. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, USA. J. Acq. Immun. Defic. Syndr. Hum Retrovirol. 9:1995;89-96.